Bayer gets warning; Dey loses drugs

> The FDA has expressed concern to Bayer about the testing and quality of pharmaceutical ingredients made at a German facility. Article

> Mylan subsidiary Dey has issued an advisory regarding the theft of two respiratory medications after a tractor-trailer was stolen in Florida. Release

> Drug delivery company OctoPlus will perform process development and clinical manufacturing of Axentis Pharma's lead product, an inhalable treatment for cystic fibrosis. Release

> Ulm, Germany, will host the European Innovation Showcase, an event featuring details of award-winning pharmaceutical manufacturing facilities, in November. Release

> Eli Lilly is creating a Development Center of Excellence to streamline and accelerate late-stage drug development, and says it will reorganize its pharmaceutical business and "significantly reduce" its cost structure by the 2011. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.